Bioenergetic Polymer for Bone Defect Repair via Metabolic Energy Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biodegradable polymer materials used in bone tissue engineering face challenges such as uncontrollable degradation rates, poor mechanical properties, and inflammatory reactions due to acidic degradation products, limiting their application in bone defect repair, especially for complex bone tissue defects where long-term bioenergy release is needed.

Innovation Solution

A bioenergetic-active material with a degradation product that is a metabolic intermediate via the tricarboxylic acid cycle or glycolysis pathway, or a polymer monomer convertible into such intermediates, including citrate, ATP, and acetyl-coenzyme A, is used to provide sustained bioenergy for tissue repair, exemplified by polyhydroxyalkanoates like poly(3-hydroxybutyrate-co-4-hydroxybutyrate) that degrades to 3-hydroxybutyric acid, promoting cell proliferation and differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If biodegradable polymer materials are used for bone tissue engineering, then biocompatibility and degradability are improved, but degradation rate control, mechanical properties, and inflammatory reactions remain problematic

Engineering Contradiction:
ImprovebiocompatibilityVSAvoiddegradation rate control
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent modifies the chemical structure of polymer materials by introducing functional groups that can regulate degradation kinetics. Specific parameter changes in polymer composition and crosslinking density enable controlled degradation rates while maintaining biocompatibility, directly addressing the contradiction between reliability and ease of operation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention employs composite polymer systems combining multiple biodegradable polymers with complementary properties. This composite approach allows independent optimization of degradation rate and mechanical strength, resolving the contradiction by distributing functional requirements across different material components.

Inventive Principle:
Principle #40Composite materials

2Reliability

If biodegradable polymer materials are used for bone tissue engineering, then biocompatibility and degradability are improved, but mechanical properties deteriorate

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidmechanical properties
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent develops composite materials combining biodegradable polymers with bioactive glass or ceramic particles. This composite structure provides the polymer matrix with enhanced mechanical strength while the inorganic components contribute to osteoconductivity, simultaneously improving strength without compromising biocompatibility.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention implements local quality enhancement by creating gradient structures where mechanical strength is concentrated in load-bearing regions while biocompatibility is optimized at the tissue interface. This spatial differentiation resolves the contradiction by assigning different functional priorities to different locations within the implant.

Inventive Principle:
Principle #3Local quality

3Duration of action of stationary object

If biodegradable polymer materials are used for bone tissue engineering, then degradability is improved, but inflammatory reactions due to acidic degradation products worsen

Engineering Contradiction:
ImprovedegradabilityVSAvoidinflammatory reaction
Core Design Contradiction:
Duration of action of stationary objectVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful acidic degradation products into beneficial signals by incorporating buffer systems that transform acid accumulation into controlled pH modulation. This approach transforms the harmful acidic environment into a beneficial stimulus for osteogenesis, resolving the contradiction between degradability and inflammatory response.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The invention introduces intermediary substances such as basic oxides or amine groups that act as buffers between the degrading polymer and the surrounding tissue. These intermediaries neutralize acidic degradation products, preventing inflammatory reactions while allowing the polymer to maintain its degradability function.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Stability of the object's composition

If existing biological scaffold materials are used, then structural support is provided, but continuous improvement of ATP stability and biomass activity cannot be achieved

Engineering Contradiction:
Improvestructural supportVSAvoidATP stability
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent designs scaffold materials with multi-functionality, combining structural support functions with bioenergetic enhancement capabilities. The material simultaneously provides mechanical framework and releases metabolic intermediates that enhance ATP stability, resolving the contradiction by integrating multiple functions into a single system.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention merges the structural support function with the bioenergetic enhancement function into a single integrated material system. By combining scaffold architecture with embedded metabolic intermediates, the material simultaneously maintains structural integrity and enhances ATP stability, eliminating the trade-off between these functions.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The bioenergetic-active material provides sustained bioenergy, enhancing cell proliferation, differentiation, and mineralization, improving bone formation and angiogenesis, and extending degradation time, making it suitable for large-sized bone defect repair with controlled structure and mechanical properties.

Implementation Method 1

a degradation product of the bioenergetic-active material is a metabolic intermediate via a tricarboxylic acid cycle and/or a glycolysis pathway

Methodology Applied
Scientific EffectTricarboxylic acid cycle:

Implementation Method 2

a degradation product of the bioenergetic-active material is a metabolic intermediate via a tricarboxylic acid cycle and/or a glycolysis pathway

Methodology Applied
Scientific EffectGlycolysis pathway:

Implementation Method 3

The biodegradable polymer material has excellent biocompatibility and degradability

Methodology Applied
Scientific EffectBiodegradation: Decomposition (biological)

Implementation Method 4

3-hydroxybutyric acid generates acetoacetate under the action of 3-hydroxybutyrate dehydrogenase, then acetoacetate and succinyl-coenzyme A (succinyl-CoA) are synthesized to obtain acetoacetyl-CoA under the action of 3-oxoacid CoA-transferase, and acetoacetyl-CoA reacts with a CoA under the action of acetyl-CoA C-acetyltransferases to obtain two acetyl-CoA

Methodology Applied
Scientific EffectBeta-oxidation:

Data Source

PatentUS20240299620A1Bioenergetic-active material and use thereof
Publication Date: 2024.09.12 SHENZHEN INST OF ADVANCED TECH
  • US20240299620A1 patent drawing
  • US20240299620A1 patent drawing
  • US20240299620A1 patent drawing

AI summary

A bioenergetic-active material and use thereof are provided, and in particular to a bioenergetic-active material is a biodegradable polymer. A degradation product of the bioenergetic-active material is a metabolic intermediate via a tricarboxylic acid cycle and/or a glycolysis pathway, or a polymer monomer capable of being converted into a metabolic intermediate via a tricarboxylic acid cycle and/or a glycolysis pathway, or a polymer monomer capable of being converted into acetyl-coenzyme A. The degradation product of the bioenergetic-active material provides bioenergy for tissue cells via a tricarboxylic acid metabolic cycle or a glycolysis pathway, so that the problem that the traditional biodegradable material cannot continuously improve the stability of ATP in cells and the activity of related biomass is solved, and the bioenergetic-active material has a wide application prospect in the field of bone tissue regeneration, particularly in the aspect of large-sized bone defect repair.